评价第二代抗精神病药的临床应用与进展。
OBJECTIVE: To evaluate the progress and clinical application of second-generation antipsychotic drugs.
而且，自从第二代抗精神病药盐酸齐拉西酮获得美国食品药品监督局批准后，该药也被包括在内。
After its approval by the US Food and Drug Administration, the second-generation antipsychotic, ziprasidone hydrochloride, was also included.
而且，自从第二代抗精神病药盐酸齐拉西酮获得美国食品药品监督局批准后，该药也被包括在内。
After its approval by the US Food and Drug Administration, the second-generation antipsychotic, ziprasidone hydrochloride, was also included.
应用推荐